Shopping Cart
- Remove All
- Your shopping cart is currently empty
REGN5678 is a bispecific antibody that targets both PSMA on prostate cancer cells and CD28 on T cells, enhancing immune activation. This drug is being developed to treat prostate cancer by redirecting T cells to tumors expressing PSMA, thereby promoting tumor cell death. Its molecular weight is 145.86 kDa.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | Inquiry | Backorder | |
5 mg | Inquiry | Backorder |
Description | REGN5678 is a bispecific antibody that targets both PSMA on prostate cancer cells and CD28 on T cells, enhancing immune activation. This drug is being developed to treat prostate cancer by redirecting T cells to tumors expressing PSMA, thereby promoting tumor cell death. Its molecular weight is 145.86 kDa. |
Alias | Regn5678 (Anti-CD28 & PSMA), Regn5678, Nezastomig |
Cas No. | 2657613-60-8 |
Storage | store at low temperature | store at -20°C | Shipping with blue ice. |
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.